Map of Pancreatica Walks and Runs

Monthly Archives: November 2013

SOX Chemo Regimen as 2nd Line for Cancer of the Pancreas

Acronyms in medicine are often a hoot.  We have the four-drug combination called FOLFIRINOX.  Recently, here at Pancreatica we reported on a study of a three-drug version of the above termed: OFF.   Now comes a review of the regimen of S-1 plus oxaliplatin by Japanese researchers, which combination they term: SOX.  In a sense SOX […]

Share Button

DNA Epigenetic Changes for the Earlier Diagnosis of Cancer of the Pancreas

In an absolutely remarkable, fascinating and possible game-changing study, Joo Mi Yi and Nita Ahuja and colleagues (primarily) from Johns Hopkins University have identified a “panel” of biomarkers based on DNA methylation of two relatively obscure genes (that can be identified in serum) for use, at least at an experimental level at this stage, for […]

Share Button

Tarceva Plus Gemcitabine After Surgery for Cancer of the Pancreas?

Gress and colleagues from the University of Marburg in Germany published the results of a Phase II trial in the October issue of the Annals of Oncology, the official journal of the European Society for Medical Oncology. They did a prospective multi-center study of 76 patients over a two-year period which offered the adjuvant regimen […]

Share Button